Advertisement
Screener

CAREDX, INC. (CDNA) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements

2.8 / 5 stars · 68/120 Roast Me

CAREDX, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements

CAREDX, INC. (CDNA) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of $1.50 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-04.

Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2025-11-04

  • CAREDX, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2018 was $12.27M, a 2951.74% increase from fiscal 2017.
  • CAREDX, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2017 was $402.00K.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month
2025-09-30$1.50M
10-Q · filed 2025-11-04
2018-12-31$12.27M
10-K · filed 2020-02-28
2017-12-31$402.00K
10-K · filed 2019-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celcuity Inc. (CELC)United States$3.887B-22.62
VERACYTE, INC. (VCYT)United States$3.904B41.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B